Acid-sensitive magnetic nanoparticles as potential drug depots

AIChE Journal

Volumn 57, Issue 6, 2011, Pages 1638-1645

  Wuang, Shy Chyi ^a,b   Neoh, Koon Gee ^a   Kang, En Tang ^a   Leckband, Deborah E ^b   Pack, Daniel W ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cancer cells; Conjugation; Doxorubicin; Hydrazone linkages; Magnetic drug targeting; Magnetic nanoparticles; Poly(methacrylic acid)

Indexed keywords

CANCER CELLS; CONJUGATION; DOXORUBICIN; HYDRAZONES; MAGNETIC DRUG TARGETING; MAGNETIC NANOPARTICLES; POLY(METHACRYLIC ACID);

ATOM TRANSFER RADICAL POLYMERIZATION; CELLS; DISEASES; FREE RADICAL REACTIONS; FUNCTIONAL POLYMERS; NANOPARTICLES; PH EFFECTS; PHYSIOLOGY; SUPERPARAMAGNETISM; TISSUE;

NANOMAGNETICS;

EID: 79955634818     PISSN: 00011541     EISSN: 15475905     Source Type: Journal    
DOI: 10.1002/aic.12373     Document Type: Article

References (34)

1. Widder KJ, Senyei AE, Scarpelli DG. Magnetic microspheres-model system for site specific drug delivery in vivo. Proc Soc Exp Biol Med. 1978; 1582: 141-146.
2. Senyei A, Widder K, Czerlinski G. Magnetic guidance of drug-carrying microspheres. J Appl Phys. 1978; 496: 3578-3583.
3. Momparler RL, Karon M, Siegel SE, Avila F. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res. 1976; 368: 2891-2895.
4. Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, Kaneda New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. Cancer Chemother Pharmacol. 2008; 616: 973-978.
5. Henderson IC, Canellos GP. Cancer of the breast-past decade number 2. N Engl J Med. 1980; 3022: 78-90.
6. Sun JB, Duan JH, Dai SL, Reri J, Zhang YD, Tian JS, Li Y. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. Cancer Lett. 2007; 258: 109-117.
7. Wilson MW, Kerlan RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, Gordon RL. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging. Radiology. 2004; 2301: 287-293.
8. Strauss H, Hemsen A, Karbe I, Lautenschlager C, Persing M, Thomssen C. Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer. Anticancer Drugs. 2008; 195: 541-545.
9. Popat R, Oakervee HE, Hallam S, Curry N, Odeh L, Foot N, Esseltine DL, Drake M, Morris C, Cavenagh JD. Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up. Br J Haematol. 2008; 1414: 512-516.
10. Ko J, Park K, Kim YS, Kim MS, Han JK, Kim K, Park RW, Kim IS, Song HK, Lee DS, Kwon IC. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (beta-amino ester) block copolymer micelles for cancer therapy. J Controlled Release. 2007; 123: 109-115.
11. Etrych T, Jelinkova M, Rihova B, Ulbrich K. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J Controlled Release. 2001; 731: 89-102.
12. Sethuraman VA, Lee MC, Bae YH. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res. 2008; 25: 657-666.
13. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 2005; 52: 325-329.
14. Zhang J, Misra RDK. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater. 2007; 3: 838-850.
15. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989; 4916: 4373-4384.
16. Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia. 2005; 217: 637-647.
17. Coughlin CT. Interstitial thermobrachytherapy. In: Nag S, editor. Principles and Practice of Brachytherapy. New York: Futura publishing, 1997: 639-647.
18. Gaya AM, Rustin GJS. Vascular disrupting agents: a new class of drug in cancer therapy. Clin Oncol. 2005; 17: 277-290.
19. Garber K. Why it hurts: researchers seek mechanisms of cancer pain. J Natl Cancer Inst. 2003; 95: 770-772.
20. Liu XQ, Guan YP, Ma ZY, Liu HZ. Surface modification and characterization of magnetic polymer nanospheres prepared by miniemulsion polymerization. Langmuir. 2004; 2023: 10278-10282.
21. Wuang SC, Neoh KG, Kang ET, Pack DW, Leckband DE. HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomaterials. 2008; 2914: 2270-2279.
22. Fan QL, Neoh KG, Kang ET, Shuter B, Wang SC. Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethyleneglycol) monomethacrylate)-grafted Fe3O4 nanoparticles: synthesis, characterization and cellular uptake. Biomaterials. 2007; 2836: 5426-5436.
23. Wuang SC, Neoh KG, Kang ET, Pack DW, Leckband DE. Synthesis and functionalization of polypyrrole-Fe3O4 nanoparticles for application in biomedicine. J Mater Chem. 2007; 17: 3354-3362.
24. Wang D, Miller SC, Liu XM, Anderson B, Wang XS, Goldring SR. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther. 2007; 9: R2.
25. Moulder JF, Stickle WF, Sobol PE, Bomben KD. Handbook of X-Ray Photoelectron Spectroscopy: A Reference Book of Standard Spectra for Identification and Interpretation of XPS Data. Minnesota: Eden-Prairie, 1992.
26. Beamson G, Briggs D. High Resolution XPS of Organic Polymers: The Scienta ESCA300 Database. Chichester: Wiley, 1992.
27. Dresco PA, Zaitsev VS, Gambino RJ, Chu B. Preparation and properties of magnetite and polymer magnetite nanoparticles. Langmuir. 1999; 15: 1945-1951.
28. Black RC, Wellstood FC. Measurements of magnetism and magnetic properties of matter. In: Clarke J, Braginski AI, editors.The SQUID Handbook, vol. II. Weinheim: Wiley-VCH, 2006: 396.
29. Tartaj P, Serna CJ. Synthesis of monodisperse superparamagnetic Fe. J Am Chem Soc. 2003; 12551: 15754-15755.
30. Brusentsov NA, Gogosov VV, Brusentsova TN, Sergeev AV, Jurchenko NY, Kuznetsov AA, Kuznetsov OA, Shumakov LI. Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro. J Magn Magn Mater. 2001; 225: 113-117.
31. Thode K, Muller RH, Kresse M. Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis-highly sensitive rapid assay for dispersion stability. J Pharm Sci. 2000; 8910: 1317-1324.
32. Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm. 1998; 1682: 221-229.
33. Zhang J, Rana S, Srivastava RS, Misra RDK. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater. 2008; 4: 40-48.
34. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 1996; 566: 1194-1198.